Home › Funds › NJ State Employees Deferred Compensation Plan › BSX

NJ State Employees Deferred Compensation Plan position in BSX

BOSTON SCIENTIFIC CORP · Health Care

NJ State Employees Deferred Compensation Plan reported holding 43,600 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2025 13F filing — a position valued at US$4.3M, representing 0.47% of its reported portfolio and ranking #42 among its reported holdings. NJ State Employees Deferred Compensation Plan has disclosed BSX holdings in 9 of the last 9 reported quarters, going back to Q3 2023.

Latest position (Q3 2025)43.60K sh
Reported value held$4.26M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How NJ State Employees Deferred Compensation Plan's BSX position evolved

NJ State Employees Deferred Compensation Plan first disclosed a stake in BSX in Q3 2023 at 55,000 shares (US$2.9M). The position peaked in Q2 2025 at 47,000 shares, worth US$5.0M. Across 9 filings, NJ State Employees Deferred Compensation Plan increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2025) shows 43,600 shares valued at US$4.3M — a reduction of -3,400 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 55.00K $2.90M New
Q4 2023 55.00K $3.18M Hold
Q1 2024 55.00K $3.77M Hold
Q2 2024 55.00K $4.24M Hold
Q3 2024 55.00K $4.61M Hold
Q4 2024 47.00K $4.20M Reduce
Q1 2025 47.00K $4.74M Hold
Q2 2025 47.00K $5.05M Hold
Q3 2025 43.60K $4.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has NJ State Employees Deferred Compensation Plan held BSX?

NJ State Employees Deferred Compensation Plan has disclosed BSX holdings in 9 of the last 9 reported quarters, going back to Q3 2023.

What is NJ State Employees Deferred Compensation Plan's current position in BSX?

As of Q3 2025, NJ State Employees Deferred Compensation Plan holds 43.60K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $4.26M, representing 0.47% of its reported portfolio and ranking #42.

Has NJ State Employees Deferred Compensation Plan been buying or selling BSX?

In the latest 13F filing (Q3 2025), NJ State Employees Deferred Compensation Plan reduced its position in BSX. The position peaked in Q2 2025 at 47.00K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.